25 May 2013
Keywords: dor, gets, fda, go, ahead, pivotal, orbec
Article | 12 January 2009
USA-based DOR BioPharma has reached an agreement with the Food and Drug Administration on the design of a confirmatory, pivotal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
24 May 2013
© 2013 thepharmaletter.com